Internal Medicine
RSSArticles
-
Pharmacology Watch: Do Statins Prevent Parkinson’s Disease?
-
Reducing Antimicrobial Toxicity: Time to Move from Mice to Men in a Clinical Trial
Clinically relevant doses of bactericidal antibiotics (quinolones, aminoglycosides and β-lactams) were shown to cause mitochondrial dysfunction and overproduction of reactive oxygen species in mammalian cells in vitro and in mice, leading to oxidative tissue damage. -
Cyclosporiasis Spreads to 20 States
The notification of the CDC of 2 laboratory-confirmed cases of cyclospora infections on June 28, 2013 was their first evidence of an outbreak. -
Clinical Briefs in Primary Care
Evidence-based updates in primary care medicine By Louis Kuritzky, MD -
FDA: Fluoroquinolones pose risk of Permanent Nerve Damage
-
Pharmacology Update: Doxylamine Succinate and Pyridoxine HCl Delayed-Release Tablets (Diclegis®)
The FDA has approved a fixed combination of doxylamine succinate and pyridoxine for the treatment of nausea and vomiting due to pregnancy. This is a reintroduction of a product widely used between 1956 and 1983. -
Internal Medicine Alert - Full May 15, 2013 Issue in PDF
-
Pharmacology Watch: New Study on Chelation Therapy Proves Controversial
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions. -
Clinical Briefs By Louis Kuritzky, MD
Risks and Benefits of an Extended 10-year Tamoxifen Regimen for Breast Cancer; Is There More Pro than Con in Probiotics in Critically Ill Adults?; The ASH Position Paper on Orthostatic Hypotension -
Fecal Transplants Promising for Clostridium difficile
The distress felt by patients with recurring bouts of Clostridium difficile diarrhea is so acute that they welcome the opportunity to accept anothers feces to bring them back to baseline. There have been more than 30 publications on the topic since it was first introduced in 1958,1 most of them in the last 10 years.